期刊文献+

2009年-2012年上海地区儿童甲型H3N2流感病毒的耐药性监测 被引量:10

Drug resistance surveillance of influenza A(H3N2) virus in children in Shanghai,2009-2012
原文传递
导出
摘要 目的了解2009年-2012年上海地区儿童流行的甲型H3N2流感病毒对金刚烷胺和奥司他韦(达菲)的耐药情况。方法收集2009年6月-2012年5月期间复旦大学儿科医院、31家上海市流感哨点医院门诊类流感患儿的鼻咽拭子标本,所有的标本抽提核酸后采用荧光RT-PCR检测甲型H3N2流感病毒。选取部分检测阳性标本行普通RTPCR进一步扩增H3N2流感病毒基质蛋白2(Matrix protein,M2)和神经氨酸酶(Neuraminidase,NA)的部分基因片段并测序,通过相关耐药位点的分子标志来评价抗病毒耐药。结果在17 312份标本中,1 148份(6.63%)检测为H3N2亚型流感病毒阳性。测序的76株甲型H3N2病毒均携带介导对金刚烷胺耐药的S31N突变标志,未发现甲型H3N2病毒株携带对奥司他韦耐药的分子标志。结论目前上海地区儿童中流行的甲型H3N2流感病毒对金刚烷胺普遍耐药,金刚烷胺不应该推荐治疗儿童流感。奥司他韦是防治甲型H3N2流感病毒敏感的药物。 Objective To investigate the drug resistance of influenza A(H3N2) virus to amantadine and oseltamivir among children in Shanghai during 2009-2011.Methods Nasopharyngeal or throat swabs were collected from the outpatient children with influenza-like illness from June 2009 to May 2012 in Children's Hospital of Fudan University and 31 influenza sentinel hospitals in Shanghai.All the specimens were tested for influenza A(H3N2) virus using real-time RT-PCR.One-step RT-PCR reaction was performed for amplification of partial M2 and NA genes of some samples.The antiviral resistance of influenza A(H3N2) virus was determined using the drug-resistant molecular markers of the M2 and NA genes.Results In 17 312samples,influenza A(H3N2) virus was detected in 1 148 samples(6.63%).Seventy-six strains of influenza A(H3N2) virus were sequenced,and all the strains were found S31N mutation in the M2 gene indicating amantadine resistance,but no amino acid mutation associated with oseltamivir resistance was found.Conclusion Given that amantadine-resistant influenza A(H3N2) virus were widely circulated among Shanghainese children in recent years,amantadine should not be recommended for the treatment of influenza in children.Oseltamivir remains a sensitive antiviral drug for the treatment and prophylaxis of influenza.
出处 《中国卫生检验杂志》 北大核心 2014年第11期1536-1539,共4页 Chinese Journal of Health Laboratory Technology
基金 Fogarty基金项目(TW005741-07)
关键词 流感病毒 耐药 金刚烷胺 奥司他韦 Influenza virus Drug-resistance Amantadine Oseltamivir
  • 相关文献

参考文献18

  • 1Barr IG, McCanley J, Cox N, et al. Epidemiological , antigenic and genetic characteristics of seasonal influenza A ( H1 N1 ) , A ( H3 N2 ) and B influenza viruses: basis for the WHO recommendation on the compositi on of influenza vaccines for use in the 2009 - 2010 North- eru Hemisphere season[J]. Vaccine, 2010, 28(5): 1156-1167.
  • 2Wu P, Goldstein E, Ho LM, et al. Excess mortality associated with influenza A and B virus in Hong Kong, 1998 -2009 [ J ]. Infect Dis, 2012, 206(2) : 1862 - 1871.
  • 3Esposito S, Molteni CG, Daleno C, et al. Impact of pandemic A/ H1N1 /2009 influenza on children and their families: Comparison with seasonal A/HIN1 and A/H3N2 influenza viruses[J]. J Infect, 2011,63(4) : 300 -307.
  • 4中华人民共和国国家卫生和计划生育委员会.流行性感冒诊断与治疗指南(2011版)[Z].2011-02-17.
  • 5Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane re- sistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005 : a cause for concern[J]. Lancet, 2005, 366(9492) : 1175 - 1181.
  • 6Thorlund K, Awad T, Boivin G, et al. Systematic review of influen- za resistance to the neuraminidase inhibitors[ J]. BMC Infect Dis, 2011, 11: 134.
  • 7Salter A, Ni Laoi B, Crowley B. Emergence and phylogenetic analy- sis of amantadine - resistant influenza A subtype H3N2 viruses in Dublin, Ireland, over six seasons from 2003/2004 to 2008/2009 [J]. Intervirology, 2011, 54(6): 305-315.
  • 8Laplante JM, Marshall SA, Shudt M, et al. Influenza antiviral re- sistance testing in New York and Wisconsin, 2006 to 2008 : method- ology and surveillance data [ J ]. J Clin Microbiol, 2009, 47 ( 5 ) : 1372 - 1378.
  • 9Hay A J, Zambon MC, Wolstenholme AJ, et al. Molecular basis of resistance of influenza A viruses to amantadine [ J ]. J Antimicrob Chemother, 1986, 18(Suppl B): 19-29.
  • 10Samson M, Pizzorno A, Abed Y, et al. Influenza virus resistance to neuraminidase inhibitors[J]. Antiviral Res, 2013, 98(2) : 174 - 185.

同被引文献100

  • 1郭元吉,董振英.1968年以来流行性感冒在我国人群中活动的概况[J].中华实验和临床病毒学杂志,1993,7(3):237-241. 被引量:16
  • 2舒跃龙,张烨,温乐英,李梓,郭俊峰,王敏,余宏杰,杨维中,郭元吉.2004年中国甲3亚型流感病毒(H3N2)抗原性及基因特性研究[J].中华实验和临床病毒学杂志,2005,19(4):362-365. 被引量:35
  • 3蓝雨,李梓,董丽波,张烨,温乐英,张彦明,王敏,郭元吉,舒跃龙.中国H3N2亚型流感病毒烷胺类药物耐药性研究[J].中华实验和临床病毒学杂志,2006,20(2):21-23. 被引量:25
  • 4洪涛.医学病毒性基础理论及其实验技术[M].北京:科学出版社,1990:661-692.
  • 5Belshe R B,Smith M H,Hall C B,Betts R,Hay A J. 1988. Ge- netic basis of resistance to rimantadine emerging during treatment of influenza virus infection [J ]. Journal of Virolo- gy, 62(5) : 1508-1512.
  • 6Bright R A,Medina M J,Xu X,Perez-Oronoz G,Wallis T R, Davis X M,Povinelli L,Cox N J,Klimov A I. 2005. Inci- dence of adamantane resistance among influenza A(H3N2) viruses isolated worldwide from 1994 to 2005:a cause for concern[J]. Lancet, 366(9492) : 1175-1181.
  • 7Ferraris O, Lina B. 2008. Mutations of neuraminidase implicated in neuraminidase iuhibitors resistance [J ]. Journal of Clini- cal Virology, 41( 1 ) : 13-19.
  • 8Hay A J,Zanbon M C,Wolstenholme A J,Skehel J J,Smith M H. 1986. Molecular basis of resistance of influenza A virus- es to amantadine[ J ]. The Journal of Antimicrobial Chemo- therapy, 18(S) : 19-29.
  • 9Hinshaw V S, Naeve C W, Webster R G, Douglas A, Skehel J J, Bryans J. 1983. Analysis of antigenic variation in equine 2 influenza A viruses[J]. Bulletin of the World Health Orga- nization, 61( 1 ) : 153-158.
  • 10Hurt A C, Lee R T,Leang S K, Cui L, Deng Y M, Phuah S P, Caldwell N,Freeman K,Komadina N,Smith D,Speers D, Kelso A,Lin R T,Maurer-Stroh S,Barr I G. 2011. In- creased detection in Australia and Singapore of a novel in- fluenza A(H1N1 ) 2009 variant with reduced oseltamivir and zanamivir sensitity due to a $247N neuraminidase mu- tation[ J ]. Euro Surveillance, 16(23 ) : 19884.

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部